XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 41,846 $ 40,148 $ 121,944 $ 100,807
In process research and development 275 0 18,080 2,000
General and administrative 11,448 9,838 33,851 27,544
Total operating expenses 53,569 49,986 173,875 130,351
Loss from operations (53,569) (49,986) (173,875) (130,351)
Other income (expense), net (4,243) 1,486 (4,881) 4,742
Net loss (57,812) (48,500) (178,756) (125,609)
Other comprehensive income:        
Foreign currency translation, net of tax 68 0 59 0
Unrealized gain (loss) on marketable securities, net of tax (293) (168) 25 389
Other comprehensive income (loss) (225) (168) 84 389
Comprehensive loss $ (58,037) $ (48,668) $ (178,672) $ (125,220)
Net loss per share, basic and diluted (in dollars per share) $ (0.80) $ (0.80) $ (2.67) $ (2.39)
Weighted average common shares outstanding, basic and diluted (in shares) 72,245,897 60,755,872 66,931,512 52,535,569